SCHEMBL8324037

SCHEMBL8324037

O=C1OCCN1C(=O)c1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 8/20 0.74
FAAH O00519 4/20 0.74
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612752 0.86 NAAA (1.00) NAAAFAAH
SCHEMBL19628792 0.86 NAAA (1.00) NAAAFAAH
SCHEMBL19612519 0.82 FAAH (1.00) NAAAFAAH
SCHEMBL11769070 0.82 POLB (0.64) NAAAFAAHPOLB
SCHEMBL16335477 0.82 NAAA (0.54) NAAAFAAHPOLB
SCHEMBL19612619 0.80 NAAA (1.00) NAAAFAAH
SCHEMBL16193763 0.80 POLB (0.78) NAAAFAAHPOLB
SCHEMBL14325303 0.79 NAAA (0.54) NAAAFAAH
SCHEMBL11705033 0.78 NAAA (0.69) NAAAFAAHPOLB
SCHEMBL8778553 0.77 HPGD (0.51) NAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074788-B Substituted heterocyclic derivatives, preparation method and application thereof 厦门大学 2019-09-20 CN disclosed
US-9598383-B2 Reactive oxygen species-based prodrugs THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-03-21 US disclosed
CN-104356082-B One class substituted heterocycle derivant and preparation method thereof 厦门大学 2016-07-13 CN disclosed
US-20150005352-A1 REACTIVE OXYGEN SPECIES-BASED PRODRUGS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-01 US disclosed
US-5972237-A USED AS COLD BLEACH ACTIVATORS OR OPTICAL BRIGHTENERS IN DETERGENTS, CLEANERS AND BLEACHES AND IN DISINFECTANTS BASF AKTIENGESELLSCHAFT (DE) 1999-10-26 US disclosed
EP-0826025-A1 USE OF HETEROCYCLIC COMPOUNDS AS ACTIVATORS FOR INORGANIC PEROXY COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 1998-03-04 EP disclosed
WO-1996036686-A1 USE OF HETEROCYCLIC COMPOUNDS AS ACTIVATORS FOR INORGANIC PEROXY COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 1996-11-21 WO disclosed
US-4505859-A Preparation of 2-haloethylamides THE DOW CHEMICAL COMPANY (US) 1985-03-19 US disclosed
US-4007168-A Process for preparing penicillins derivatives PALOMO COLL A L 1977-02-08 US disclosed
US-3947465-A 3-Alkylsilyl-2-oxazolidonone compounds and synthesis thereof PALOMO COLL A L 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005352-A1 REACTIVE OXYGEN SPECIES-BASED PRODRUGS ROS1, NOX4, NOX1 NAAA 2323/4885FAAH 4085/4885POLB 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.